(1995). Altered relation between circulating levels of insulin-like growth factorbinding protein-1 and insulin in growth hormone-deﬁcient patients and insulin-dependent diabetic patients compared to that in healthy subjects.
(1991). Comparison of acid ethanol extraction and acid gel ﬁltration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand. Acta Endocrinologica
(1990). Decreased sex hormone binding globulin (SHBG) and insulin-like growth factor binding protein (IGFBP-1) in extreme obesity. Clinical Endocrinology
(1999). Diagnosis and Classiﬁcation of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1. Diagnosis and Classiﬁcation of Diabetes Mellitus. Geneva: World Health Organization,
Dose–response characteristics for suppression of low molecular weight plasma insulin-like growth factor-binding protein by insulin.
(2007). Effect of liver fat on insulin clearance.
(2008). from http://www.who.int/bmi/index.jsp?intro
(2006). Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clinical Research in Cardiology
(2006). Gender-speciﬁc care of the patient with diabetes: review and recommendations. Gender Medicine
(1995). Identiﬁcation of estrogen regulated genes in Fe33 rat hepatoma cells by differential display polymerase chain reaction and their hormonal regulation in rat liver and uterus.
Increased levels of triglycerides, BMI and blood pressure and low physical activity increase the risk of diabetes in Swedish women. A prospective 18-year follow-up of the BEDA study.
Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis.
(1992). Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans.
(2008). Insulin-like growth factor binding protein 1 as a novel speciﬁc marker of hepatic insulin sensitivity.
(2000). Insulin-like growth factor binding protein-1 (IGFBP-1) and IGF-I during oral and transdermal estrogen replacement therapy: relation to lipoprotein(a) levels. Atherosclerosis
Insulin-like growth factor binding protein-1: recent ﬁndings and new directions.
(2008). Insulin-like growth factor-(IGF)-axis, inﬂammation, and glucose intolerance among older adults.
(1996). Insulin-like growth factor-binding protein-1 as a marker for hyperinsulinemia in obese menopausal women.
(2008). Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men. Diabetologia
(2010). Lewitt and others
(2009). Low levelsof insulin-like growthfactor-bindingprotein-1(IGFBP-1)are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): the So ¨dera ˚kra Cardiovascular Risk Factor Study. Diabetes & Metabolism
(1988). Metabolicregulationof thegrowthhormone independent insulin-like growth factor binding protein in human plasma. Acta Endocrinologica
(1991). Oral contraceptives increase insulin-like growth factor binding protein-1 in women with polycytic ovarian disease. Fertility and Sterility
Organisation. BMI Classiﬁcation. Retrieved
(2005). Prevention of type 2 diabetes. Current Molecular Medicine
(2008). Psychological distress and risk of pre-diabetes and type 2 diabetes in a prospective study of Swedish middle-aged men and women. Diabetic Medicine
(1996). Reduced insulinlike growth factor binding protein-1 (IGFBP-1) levels correlate with increased cardiovascular risk in noninsulin dependent diabetes mellitus (NIDDM).
(1984). Roovete A & Hall K. Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding potein isolated from human amniotic ﬂuid. Acta Endocrinologica
(1995). Rotnitzky A & Manson JE. Weight gain as a risk factorforclinical diabetes mellitusinwomen.Annalsof Internal Medicine
(2005). Sex hormone-binding globulin and insulin-like growth factor-binding protein-1 as indicators of metabolic syndrome, cardiovascular risk, and mortality in elderly men.
(2005). Testosterone and estradiol regulate free insulin-like growth factor I (IGF-I), IGF binding protein 1 (IGFBP-1), and dimeric IGF-I/IGFBP-1 concentrations.
(2001). The insulin-like growth factor-I system and hormone replacement therapy. Fertility and Sterility
(2004). The metabolic syndrome: an emerging health epidemic in women.
The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study.
(2001). White A & Gibson JM. Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations. Diabetologia